Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Net Income | 50.21% | 33.85% | -- | -- | -- |
| Total Depreciation and Amortization | -29.06% | -8.68% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -187.72% | -186.45% | -- | -- | -- |
| Change in Net Operating Assets | 91.60% | 90.92% | -- | -- | -- |
| Cash from Operations | -5,184.00% | -319.17% | -- | -- | -- |
| Capital Expenditure | -2,390.35% | -2,058.94% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,390.35% | -2,058.94% | -- | -- | -- |
| Total Debt Issued | 0.94% | -- | -- | -- | -- |
| Total Debt Repaid | 10.40% | -144.76% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.99% | 1,341.65% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.24% | 397.96% | -- | -- | -- |